Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.

LAG3 anticorps (AA 29-450)

Name: LAG3 anticorps (AA 29-450)
Brand: antibodies-online
SKU: ABIN7158613
Price: 358.9 EUR
Availability: InStock

LAG3 Reactivité: Humain WB, ELISA, IF Hôte: Lapin Polyclonal unconjugated

Western Blot Positive WB detected in: HepG2 whole cell lysate All lanes: LAG3 antibody at 4. (LAG3 anticorps (AA 29-450))

Immunofluorescence staining of HepG2 cells with ABIN7158613 at 1:66, counter-stained with DAPI. (LAG3 anticorps (AA 29-450))

2 images

N° du produit ABIN7158613

Fiche de données

Antigène Voir toutes LAG3 Anticorps

LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
Épitope
15

14

9

7

6

4

3

3

3

3

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1
AA 29-450
Reactivité
87

39

10

5

4

2

1

1

1
Humain
Hôte
51

35

12

4
Lapin
Anticorps secondaires appropriés
Clonalité
52

47

1
Polyclonal
Conjugué
52

7

6

4

4

3

3

3

3

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
Cet anticorp LAG3 est non-conjugé
Application
68

35

33

30

25

22

15

13

13

10

10

5

5

2

2

1

1

1

1

1

1

1

1
Western Blotting (WB), ELISA, Immunofluorescence (IF)

Réactivité croisée

Humain

Purification

>95%, Protein G purified

Immunogène

Recombinant Human Lymphocyte activation gene 3 protein (29-450AA)

Isotype

IgG

Top Product

Discover our top product LAG3 Anticorps primaire
anti-Lymphocyte-Activation Gene 3 (LAG3) (AA 103-132) antibody
LAG3 Reactivité: Humain, Souris WB, FACS, IHC (p) Hôte: Lapin Polyclonal RB21775 unconjugated

anti-Lymphocyte-Activation Gene 3 (LAG3) antibody
LAG3 Reactivité: Humain WB, ELISA, IHC, FACS, ICC, Neut Hôte: Souris Monoclonal 3A4A10 unconjugated

anti-Lymphocyte-Activation Gene 3 (LAG3) (AA 103-132) antibody
LAG3 Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated

anti-Lymphocyte-Activation Gene 3 (LAG3) (AA 29-450) antibody
LAG3 Reactivité: Humain WB, ELISA, IHC, FACS Hôte: Souris Monoclonal 8B12E10 unconjugated

anti-Lymphocyte-Activation Gene 3 (LAG3) (N-Term) antibody
LAG3 Reactivité: Humain WB, ELISA, IHC, IP, FACS, ICC Hôte: Souris Monoclonal L4-PL33 unconjugated

anti-Lymphocyte-Activation Gene 3 (LAG3) (AA 1-360) antibody
LAG3 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated

anti-Lymphocyte-Activation Gene 3 (LAG3) (AA 244-487) antibody
LAG3 Reactivité: Humain WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated

anti-Lymphocyte-Activation Gene 3 (LAG3) (AA 209-451) antibody
LAG3 Reactivité: Rat WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated

anti-Lymphocyte-Activation Gene 3 (LAG3) (AA 201-300) antibody
LAG3 Reactivité: Humain, Souris WB, ELISA, ICC, IHC (p), IF (p), IHC (fro), IF (cc) Hôte: Lapin Polyclonal unconjugated

anti-Lymphocyte-Activation Gene 3 (LAG3) antibody
LAG3 Reactivité: Souris IP, FACS, BP Hôte: Lapin Chimeric C9B7W unconjugated Recombinant Antibody

Indications d'application

Recommended dilution: WB:1:500-1:5000, IF:1:50-1:200,

Restrictions

For Research Use only
Format

Liquid

Buffer

Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur

ProClin

Précaution d'utilisation

This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock

-20 °C,-80 °C

Stockage commentaire

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Antigène

LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Autre désignation

LAG3 (LAG3 Produits)

Synonymes

anticorps CD223, anticorps LAG-3, anticorps Ly66, anticorps lymphocyte activating 3, anticorps lymphocyte-activation gene 3, anticorps LAG3, anticorps Lag3

Sujet

Background: Involved in lymphocyte activation. Binds to HLA class-II antigens.
Aliases: CD223 antibody, CD223 antigen antibody, FDC protein antibody, LAG-3 antibody, Lag3 antibody, LAG3_HUMAN antibody, Lymphocyte activating 3 antibody, Lymphocyte activation gene 3 antibody, Lymphocyte activation gene 3 protein antibody, Protein FDC antibody

UniProt

P18627

Pathways

Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints